$CYDY
CytoDyn Inc.

2021 Q3 Form 10-Q Financial Statement

#000155837021013132 Filed on October 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $41.00K $0.00
YoY Change
Cost Of Revenue $1.000K
YoY Change
Gross Profit $40.00K
YoY Change
Gross Profit Margin 97.56%
Selling, General & Admin $7.617M $9.875M
YoY Change -22.87% 224.2%
% of Gross Profit 19042.5%
Research & Development $13.78M $15.19M
YoY Change -9.24% 67.73%
% of Gross Profit 34460.0%
Depreciation & Amortization $276.0K $505.0K
YoY Change -45.35% -4.91%
% of Gross Profit 690.0%
Operating Expenses $13.78M $15.19M
YoY Change -9.24% 20.23%
Operating Profit -$21.64M -$25.57M
YoY Change -15.37% 102.4%
Interest Expense -$3.194M -$5.254M
YoY Change -39.21% -226.39%
% of Operating Profit
Other Income/Expense, Net -$35.00K $94.00K
YoY Change -137.23%
Pretax Income -$45.34M -$30.83M
YoY Change 47.05% 90.74%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$45.34M -$30.83M
YoY Change 47.05% 90.74%
Net Earnings / Revenue -110578.05%
Basic Earnings Per Share -$0.07
Diluted Earnings Per Share -$0.07 -$53.87K
COMMON SHARES
Basic Shares Outstanding 660.2M 568.2M
Diluted Shares Outstanding 632.6M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.533M $18.20M
YoY Change -64.1% 913.46%
Cash & Equivalents $6.533M $18.20M
Short-Term Investments
Other Short-Term Assets $4.654M $3.202M
YoY Change 45.35% 128.88%
Inventory $91.56M $58.47M
Prepaid Expenses $3.381M
Receivables $41.00K
Other Receivables $0.00
Total Short-Term Assets $102.8M $79.88M
YoY Change 28.68% 2396.13%
LONG-TERM ASSETS
Property, Plant & Equipment $129.0K $527.0K
YoY Change -75.52% 1584.89%
Goodwill
YoY Change
Intangibles $1.390M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.184M $13.49M
YoY Change -83.81% -11.2%
TOTAL ASSETS
Total Short-Term Assets $102.8M $79.88M
Total Long-Term Assets $2.184M $13.49M
Total Assets $105.0M $93.36M
YoY Change 12.43% 407.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.90M $21.35M
YoY Change 208.65% 77.21%
Accrued Expenses $12.36M $36.94M
YoY Change -66.53% 1418.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $51.33M $18.12M
YoY Change 183.23% 391.79%
Total Short-Term Liabilities $129.6M $76.42M
YoY Change 69.64% 231.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $13.86M
YoY Change -100.0% 5908.41%
Other Long-Term Liabilities $519.0K $314.0K
YoY Change 65.29% -83.33%
Total Long-Term Liabilities $519.0K $14.17M
YoY Change -96.34% 570.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $129.6M $76.42M
Total Long-Term Liabilities $519.0K $14.17M
Total Liabilities $130.2M $90.59M
YoY Change 43.68% 259.77%
SHAREHOLDERS EQUITY
Retained Earnings -$599.4M
YoY Change
Common Stock $644.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.19M $2.768M
YoY Change
Total Liabilities & Shareholders Equity $105.0M $93.36M
YoY Change 12.43% 407.77%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$45.34M -$30.83M
YoY Change 47.05% 90.74%
Depreciation, Depletion And Amortization $276.0K $505.0K
YoY Change -45.35% -4.91%
Cash From Operating Activities -$31.74M -$40.95M
YoY Change -22.48% 169.57%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $59.00K
YoY Change -86.44% 1144.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.000K -$59.00K
YoY Change -86.44% 1144.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.348M 44.93M
YoY Change -90.32% 232.2%
NET CHANGE
Cash From Operating Activities -31.74M -40.95M
Cash From Investing Activities -8.000K -59.00K
Cash From Financing Activities 4.348M 44.93M
Net Change In Cash -27.40M 3.921M
YoY Change -798.83% -334.69%
FREE CASH FLOW
Cash From Operating Activities -$31.74M -$40.95M
Capital Expenditures $8.000K $59.00K
Free Cash Flow -$31.75M -$41.01M
YoY Change -22.58% 169.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2021Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2021Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q3 dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2021Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2020Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2021Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q3 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021Q3 dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Document Type
DocumentType
10-Q
CY2021Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 dei Document Period End Date
DocumentPeriodEndDate
2021-08-31
CY2021Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 dei Entity File Number
EntityFileNumber
000-49908
CY2021Q3 dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC.
CY2021Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1887078
CY2021Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1111 Main Street
CY2021Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 660
CY2021Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2021Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2021Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98660
CY2021Q3 dei City Area Code
CityAreaCode
360
CY2021Q3 dei Local Phone Number
LocalPhoneNumber
980-8524
CY2021Q3 dei Security12b Title
Security12bTitle
None.
CY2021Q3 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2021Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q3 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
660191552
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6533000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33943000
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41000
CY2021Q3 us-gaap Inventory Net
InventoryNet
91558000
CY2021Q2 us-gaap Inventory Net
InventoryNet
93479000
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3381000
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
616000
CY2021Q3 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1264000
CY2021Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1543000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
102786000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
129581000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
665000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
712000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
134000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1390000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1653000
CY2021Q3 us-gaap Assets
Assets
104970000
CY2021Q2 us-gaap Assets
Assets
132080000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
65938000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
65897000
CY2021Q3 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
6891000
CY2021Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
19073000
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2244000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2007000
CY2021Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
3067000
CY2021Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
2647000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
162000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
51333000
CY2021Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
62747000
CY2021Q3 cydy Warrant Exercise Proceeds Held In Trust
WarrantExerciseProceedsHeldInTrust
9000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
129644000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
152546000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
519000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
552000
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
519000
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
552000
CY2021Q3 us-gaap Liabilities
Liabilities
130163000
CY2021Q2 us-gaap Liabilities
Liabilities
153098000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
644120000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
644000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
626123000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
643677000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
625680000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
626000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
516816000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
489650000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-542653000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-511294000
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
443000
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
443000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-25193000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-21018000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104970000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132080000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41000
CY2021Q3 us-gaap Revenues
Revenues
41000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
1000
CY2021Q3 us-gaap Gross Profit
GrossProfit
40000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7617000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9875000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13784000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15188000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
276000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
505000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
21677000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
25568000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21637000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25568000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-4651000
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1941000
CY2021Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
35000
CY2020Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
10000
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
952000
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1339000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000
CY2021Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
9000
CY2020Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3345000
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1686000
CY2020Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
566000
CY2021Q3 cydy Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt
InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt
2710000
CY2020Q3 cydy Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt
InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt
5264000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30939000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30832000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30939000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-30832000
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
632597000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
555531000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-21018000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
18495000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
189000
CY2021Q3 cydy Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
503000
CY2021Q3 cydy Adjustments To Additional Paid In Capital Inducement Interest
AdjustmentsToAdditionalPaidInCapitalInducementInterest
9000
CY2021Q3 cydy Dividends Accrued
DividendsAccrued
420000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2597000
CY2021Q3 cydy Issuance Of Stock Value Legal Settlement
IssuanceOfStockValueLegalSettlement
1744000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30939000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-25193000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
9537000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-39000
CY2020Q3 cydy Stock Issued For Incentive Compensation And Tendered For Income Tax Value
StockIssuedForIncentiveCompensationAndTenderedForIncomeTaxValue
828000
CY2020Q3 cydy Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
13469000
CY2020Q3 cydy Adjustments To Additional Paid In Capital Inducement Interest
AdjustmentsToAdditionalPaidInCapitalInducementInterest
3345000
CY2020Q3 cydy Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Excluding Legal Fees
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsExcludingLegalFees
364000
CY2020Q3 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
0.25
CY2020Q3 cydy Dividends Declared And Paid
DividendsDeclaredAndPaid
243000
CY2020Q3 cydy Dividends Accrued
DividendsAccrued
420000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2086000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-30832000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2768000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30939000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-30832000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
276000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
505000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
952000
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1339000
CY2021Q3 cydy Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Litigation Settlement
AdjustmentToReconcileNetLossToNetCashUsedInOperatingActivitiesLitigationSettlement
1744000
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
1131000
CY2021Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
9000
CY2020Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3345000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2597000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3692000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4651000
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41000
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-790000
CY2020Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39327000
CY2021Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2486000
CY2020Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-199000
CY2021Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10453000
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20127000
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31741000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40948000
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59000
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8000
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59000
CY2021Q3 cydy Proceeds From Warrant Transactions Net
ProceedsFromWarrantTransactionsNet
775000
CY2020Q3 cydy Proceeds From Warrant Transactions Net
ProceedsFromWarrantTransactionsNet
7441000
CY2021Q3 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
2872000
CY2021Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
503000
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
13456000
CY2021Q3 cydy Proceeds From Warrant And Stock Option Exercises Held In Trust
ProceedsFromWarrantAndStockOptionExercisesHeldInTrust
9000
CY2020Q3 cydy Proceeds From Warrant And Stock Option Exercises Held In Trust
ProceedsFromWarrantAndStockOptionExercisesHeldInTrust
13000
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
189000
CY2020Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
39000
CY2020Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
778000
CY2020Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000000
CY2020Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
243000
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4348000
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44928000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27401000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3921000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33943000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14292000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6542000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18213000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6533000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18200000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
13000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6542000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18213000
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
35000
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
14950000
CY2020Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9537000
CY2021Q3 cydy Dividends On Convertible Preferred Stock Incurred But Not Yet Paid.
DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.
420000
CY2020Q3 cydy Dividends On Convertible Preferred Stock Incurred But Not Yet Paid.
DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.
420000
CY2021Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Consolidated Financial Statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease could have on our significant accounting estimates and assumptions. The Company’s estimates are based on historical experience and on various market and other relevant, appropriate assumptions. Significant estimates include, but are not limited to, those relating to stock-based compensation, revenue recognition, research and development expenses, determination of right of use assets under lease transactions and related lease obligations, commitments and contingencies, and the assumptions used to value warrants, warrant modifications and useful lives for property and equipment and related depreciation calculations. Actual results could differ from these estimates.</p>
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26034000
CY2021Q3 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y6M7D
CY2021Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year and prior quarter amounts shown in the accompanying Consolidated Financial Statements have been reclassified to conform to the current period presentation. These reclassifications did not have any effect on the Company’s financial position, results of operations, stockholders’ (deficit) equity, or net cash flows as previously reported.</p>
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30900000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-542700000
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6300000
CY2021Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
33700000
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 cydy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2021Q3 cydy Number Of Portions Of Biologic License Application Bla Resubmitted
NumberOfPortionsOfBiologicLicenseApplicationBlaResubmitted
2
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28085000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
65524000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
65394000
CY2021Q3 us-gaap Inventory Net
InventoryNet
91558000
CY2021Q2 us-gaap Inventory Net
InventoryNet
93479000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
35931000
CY2021Q3 cydy Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesOutstanding
10700000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
6800000
CY2021Q3 cydy Inventory With Shelf Life Less Than One Year
InventoryWithShelfLifeLessThanOneYear
4547000
CY2021Q3 cydy Inventory With Shelf Life From One To Two Years
InventoryWithShelfLifeFromOneToTwoYears
17457000
CY2021Q3 cydy Inventory With Shelf Life From Two To Three Years
InventoryWithShelfLifeFromTwoToThreeYears
550000
CY2021Q3 cydy Inventory With Shelf Life From Three To Four Years
InventoryWithShelfLifeFromThreeToFourYears
46862000
CY2021Q3 cydy Inventory With Shelf Life From Four To Five Years
InventoryWithShelfLifeFromFourToFiveYears
704000
CY2021Q3 cydy Inventory With Shelf Life Greater Than Five Years
InventoryWithShelfLifeGreaterThanFiveYears
23265000
CY2021Q3 us-gaap Inventory Gross
InventoryGross
93385000
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1827000
CY2021Q3 us-gaap Inventory Net
InventoryNet
91558000
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
1100000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
65900000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
65900000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
956000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4005000
CY2021Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1216000
CY2021Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11008000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4719000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4060000
CY2021Q3 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
6891000
CY2021Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
19073000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1200000
CY2021Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11000000.0
CY2021Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
10600000
CY2021Q3 cydy Share Based Compensation Number Of Active Plans
ShareBasedCompensationNumberOfActivePlans
1
CY2021Q3 cydy Share Based Compensation Number Of Inactive Plans
ShareBasedCompensationNumberOfInactivePlans
1
CY2021Q3 cydy Percentage Of Increase In Shares Issued On Proportion Of Outstanding Capital Stock On Last Day Of Each Fiscal Year
PercentageOfIncreaseInSharesIssuedOnProportionOfOutstandingCapitalStockOnLastDayOfEachFiscalYear
0.01
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
26100000
CY2021Q3 cydy Issuance Of Stock Shares Legal Settlement
IssuanceOfStockSharesLegalSettlement
1600000
CY2021Q3 cydy Warrants Issued In Legal Settlement Expiration Period
WarrantsIssuedInLegalSettlementExpirationPeriod
P7Y
CY2021Q3 cydy Warrants Issued In Legal Settlement Exercise Price
WarrantsIssuedInLegalSettlementExercisePrice
0.40
CY2021Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
61573000
CY2021Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.95
CY2021 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P4Y4M24D
CY2021Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
68756000
CY2021Q3 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
5268000
CY2021Q3 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
1.15
CY2021Q3 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
1632000
CY2021Q3 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.66
CY2021Q3 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
5766000
CY2021Q3 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.73
CY2021Q3 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
59443000
CY2021Q3 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.99
CY2021Q3 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P4Y1M20D
CY2021Q3 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
36673000
CY2021Q3 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
52537000
CY2021Q3 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.84
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6446000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6446000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5056000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4793000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1390000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1653000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2021Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
10000000.0
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
604000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
384000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
85000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
85000
CY2021Q3 cydy Finite Lived Intangible Assets Amortization Expense Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseThereafter
232000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1390000
CY2021Q3 cydy Number Of License Agreements
NumberOfLicenseAgreements
2
CY2021Q3 cydy Annual Charges Under Agreement
AnnualChargesUnderAgreement
600000
CY2021Q3 cydy Annual Charges Under Agreement
AnnualChargesUnderAgreement
800000
CY2021Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
100000
CY2021Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
100000
CY2021Q3 cydy Number Of Lawsuits Consolidated
NumberOfLawsuitsConsolidated
3

Files In Submission

Name View Source Status
0001558370-21-013132-index-headers.html Edgar Link pending
0001558370-21-013132-index.html Edgar Link pending
0001558370-21-013132.txt Edgar Link pending
0001558370-21-013132-xbrl.zip Edgar Link pending
cydy-20210831.xsd Edgar Link pending
cydy-20210831x10q.htm Edgar Link pending
cydy-20210831x10q_htm.xml Edgar Link completed
cydy-20210831xex10d3.htm Edgar Link pending
cydy-20210831xex31d1.htm Edgar Link pending
cydy-20210831xex31d2.htm Edgar Link pending
cydy-20210831xex32d1.htm Edgar Link pending
cydy-20210831xex32d2.htm Edgar Link pending
cydy-20210831_cal.xml Edgar Link unprocessable
cydy-20210831_def.xml Edgar Link unprocessable
cydy-20210831_lab.xml Edgar Link unprocessable
cydy-20210831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending